Europe Colorectal Cancer Screening Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Europe Colorectal Cancer Screening Market is segmented by screening tests (stool-based tests, colonoscopy, CT colonography (virtual colonoscopy), flexible sigmoidoscopy and other tests), and end-user (hospitals and diagnostic centers), and geography (Germany, United Kingdom, France, Italy, Spain and Rest of Europe). The report offers the value (in USD million) for the above segments.

Europe Colorectal Cancer Screening Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Europe Colorectal Cancer Screening Industry Overview

The Europe colorectal cancer screening market is competitive and consists of several significant players across the region. The key players are developing novel products to compete with the existing products, while others are acquiring and partnering with the other companies trending in the market to expand their presence. Some market players in the studied market are Abbott Laboratories, Epigenomics Inc., Exact Sciences Corporation, F. Hoffmann-La Roche AG, Novigenix SA, Quidel Corporation, Siemens Healthineers AG, Sysmex Corporation, Olympus Corporation, Stryker, and FUJIFILM Corporation.

Europe Colorectal Cancer Screening Market Leaders

  1. Abbott Laboratories

  2. Epigenomics Inc.

  3. Exact Sciences Corporation

  4. F. Hoffmann-La Roche AG

  5. Novigenix SA

  6. *Disclaimer: Major Players sorted in no particular order
Europe Colorectal Cancer Screening Market Concentration

Europe Colonoscopy Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?